RGC
Regencell Bioscience Holdings Ltd
6.30$
+1.8%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
Regencell Bioscience Holdings Ltd (RGC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -3.1 million $. Tick rows to compare them in a chart.
Tick rows to compare them in a chart (up to 4)
| Line item | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 373 | 476 | 387 | 386 | 304 | 800 | 270 | 411 | 259 | 353 | 347 | 347 | 349 | 434 | 411 | 410 | -0.4 | -0.7 | -0.8 | -5.3 | -5.0 | -4.0 | -3.1 | |
| 134 | 158 | 174 | 199 | 197 | 183 | 202 | 202 | 226 | 202 | 186 | 205 | 212 | 217 | 231 | 255 | 0.0 | 0.0 | 0.0 | 0.6 | 0.8 | 0.7 | 0.4 | |
| 2.0 | 5.0 | 5.0 | 5.0 | 8.0 | 5.0 | 5.0 | 5.9 | 8.4 | 7.9 | 10 | 9.3 | 9.4 | 8.3 | 8.8 | 9.2 | – | 0.0 | 0.0 | 2.8 | 0.9 | 0.4 | 0.2 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.7 | 2.7 | 2.7 | 2.6 | – | – | – | |
| 24 | 102 | 50 | 88 | -30 | 272 | -92 | 44 | -51 | -19 | -71 | -1.5 | -43 | 36 | -67 | -35 | 0.0 | 0.1 | 0.6 | -1.0 | -0.5 | -0.6 | 0.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 109 | 98 | 87 | 89 | 112 | 157 | 186 | 215 | 250 | 0.1 | 0.1 | 0.0 | 0.8 | 0.0 | 0.0 | 0.2 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -0.1 | -0.1 | -11 | -11 | 0.1 | 5.2 | 2.7 | |
| 19 | 799 | – | 175 | 179 | 485 | – | 111 | 327 | 130 | 287 | 132 | 295 | 139 | 139 | 139 | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -0.4 | -205 | -253 | -110 | -281 | -147 | – | – | -229 | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.5 | 1.0 | 0.6 | -0.4 | 0.0 | 0.0 | – | |
| -50 | -281 | – | -191 | -186 | -480 | – | -142 | -300 | -204 | -307 | 83 | -332 | -179 | -160 | -17 | 0.5 | 1.0 | 0.4 | 22 | 0.1 | 0.1 | – | |
| 208 | 12 | 81 | -47 | -34 | 273 | -68 | 158 | -123 | 48 | -144 | 172 | -133 | 73 | 27 | -18 | 0.1 | 0.1 | -0.3 | 6.4 | -4.9 | 1.4 | -0.5 | |
| 373 | 476 | 387 | 386 | 304 | 800 | 270 | 302 | 161 | 266 | 257 | 235 | 192 | 249 | 196 | 160 | -0.4 | -0.8 | -0.8 | -6.0 | -5.0 | -4.0 | -3.3 |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.